Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Orangeburg, SC
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Houston, TX
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Wellington, FL
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Wellington, FL
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
New Orleans, LA
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Middelburg,
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Middelburg,
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
mi
from
Cypress, CA
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
mi
from
Aventura, FL
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
mi
from
Lenexa, KA
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
mi
from
Raleigh, NC
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated:  12/13/2016
Clinical Research Facility
mi
from
Seattle, WA
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
A Randomized, Double-Blind, Placebo-controlled, Ascending, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Mild Atopic Asthma
Status: Enrolling
Updated: 12/13/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Birmingham, AL
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
New Haven, CT
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Chicago, IL
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Iowa City, IA
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Baltimore, MD
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Cleveland, OH
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
Clinical Research Facility
mi
from
Galveston, TX
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/19/2016
mi
from
Calgary,
A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
A Multicenter Longitudinal Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/19/2016
mi
from
Calgary,
Click here to add this to my saved trials
The Effects of a Standardized Management Plan on Children With Critical Asthma
The Effects of a Standardized Clinical Assessment Management Plan (SCAMP) on Clinical Outcomes in Children With Critical Asthma
Status: Enrolling
Updated:  1/4/2017
Boston Children's Hospital
mi
from
Boston, MA
The Effects of a Standardized Management Plan on Children With Critical Asthma
The Effects of a Standardized Clinical Assessment Management Plan (SCAMP) on Clinical Outcomes in Children With Critical Asthma
Status: Enrolling
Updated: 1/4/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Bakersfield, CA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Long Beach, CA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Miami, FL
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Albany, GA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Albany, GA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
New York, NY
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Tulsa, OK
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Houston, TX
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
McKinney, TX
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
McKinney, TX
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
Clinical Research Facility
mi
from
Tacoma, WA
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated:  1/12/2017
mi
from
Brisbane,
A Study of Lebrikizumab in Patients With Severe Asthma Who Depend on Oral Corticosteroids (OCS)
A Phase II, Randomized, Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Oral Corticosteroid-Sparing Effect of Lebrikizumab in Patients With Severe Corticosteroid Dependent Asthma
Status: Enrolling
Updated: 1/12/2017
mi
from
Brisbane,
Click here to add this to my saved trials
World Trade Center Adolescent Health Study
Early Identification of World Trade Center Conditions in Adolescents
Status: Enrolling
Updated:  1/23/2017
NYU School of Medicine
mi
from
New York, NY
World Trade Center Adolescent Health Study
Early Identification of World Trade Center Conditions in Adolescents
Status: Enrolling
Updated: 1/23/2017
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Mobile, AL
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Little Rock, AR
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Fresno, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Fullerton, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Fullerton, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Huntington Beach, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Inglewood, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Inglewood, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Irvine, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Irvine, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Long Beach, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Orange, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Spring Valley, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Stockton, CA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Stockton, CA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Colorado Springs, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Denver, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Lakewood, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Lakewood, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Wheat Ridge, CO
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Waterbury, CT
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Waterbury, CT
Click here to add this to my saved trials